Herold Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Buy |
7,413
+228
| +3% | +$25.3K | 0.17% | 132 |
|
|
2025
Q1 | $805K | Sell |
7,185
-560
| -7% | -$62.8K | 0.18% | 133 |
|
|
2024
Q4 | $715K | Buy |
7,745
+29
| +0.4% | +$2.68K | 0.16% | 148 |
|
|
2024
Q3 | $647K | Buy |
7,716
+474
| +7% | +$39.7K | 0.14% | 161 |
|
|
2024
Q2 | $497K | Buy |
7,242
+155
| +2% | +$10.6K | 0.11% | 181 |
|
|
2024
Q1 | $519K | Sell |
7,087
-201
| -3% | -$14.7K | 0.13% | 173 |
|
|
2023
Q4 | $591K | Sell |
7,288
-1,033
| -12% | -$83.7K | 0.16% | 144 |
|
|
2023
Q3 | $624K | Buy |
8,321
+2,016
| +32% | +$151K | 0.19% | 135 |
|
|
2023
Q2 | $486K | Sell |
6,305
-107
| -2% | -$8.25K | 0.15% | 154 |
|
|
2023
Q1 | $532K | Buy |
6,412
+348
| +6% | +$28.9K | 0.18% | 132 |
|
|
2022
Q4 | $521K | Buy |
6,064
+5
| +0.1% | +$429 | 0.22% | 109 |
|
|
2022
Q3 | $373K | Buy |
6,059
+1,293
| +27% | +$79.6K | 0.18% | 132 |
|
|
2022
Q2 | $294K | Buy |
4,766
+106
| +2% | +$6.54K | 0.13% | 155 |
|
|
2022
Q1 | $277K | Buy |
4,660
+703
| +18% | +$41.8K | 0.1% | 170 |
|
|
2021
Q4 | $287K | Buy |
3,957
+203
| +5% | +$14.7K | 0.11% | 167 |
|
|
2021
Q3 | $262K | Buy |
+3,754
| New | +$262K | 0.1% | 168 |
|